4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001567619-21-012871
Director acquired 4,610 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Namouni Fouad Director | 2021-06-30 | Grant or award | +4,610 | 4,610 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Namouni Fouad Director | 2021-06-30 | Grant or award · Stock Option (Right to Buy) | +22,750 | 22,750 | D: show line 2 in the form |
Loading xslF345X03/doc1.xml…